Eastman Chemical Company(EMN)Earnings, Financials & Key Ratios

EMN•NYSE

$75.74

$8.66B mkt cap·18.5× P/E·Price updated May 6, 2026

SectorBasic Materials IndustrySpecialty Chemicals Sub-IndustrySpecialty polymers and engineered plastics

AboutEastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films, and aftermarket applied film products for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non- phthalate plasticizers to the industrial chemicals and processing, building and construction, health and wellness, and agrochemicals. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.Show more

Revenue$8.75B-6.7%
EBITDA$1.44B-23.4%
Net Income$474M-47.6%
EPS (Diluted)4.10-46.5%
Gross Margin21.07%-13.7%
EBITDA Margin16.5%-17.9%
Operating Margin10.64%-27.5%
Net Margin5.42%-43.9%
ROE7.97%-49.9%
ROIC6.71%-33.7%
Debt/Equity0.84-6.4%
Interest Coverage3.73-37.7%

Technical→

EMN Key Insights

Eastman Chemical Company (EMN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓12 consecutive years of dividend growth
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 4.4%
✓Trading at only 1.5x book value

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

EMN Price & Volume

Eastman Chemical Company (EMN) stock price & volume — 10-year historical chart

Loading chart...

EMN Growth Metrics

Eastman Chemical Company (EMN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-0.88%

5 Years0.67%

3 Years-5.99%

TTM-7.72%

Profit CAGR

10 Years-5.65%

5 Years-0.17%

3 Years-15.76%

TTM-56.72%

EPS CAGR

10 Years-3.17%

5 Years3.22%

3 Years-13.57%

TTM-55.98%

Return on Capital

10 Years9.83%

5 Years9.63%

3 Years9.36%

Last Year7.53%

EMN Recent Earnings

Eastman Chemical Company (EMN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 9/12 qtrs (75%)●Beat Revenue 5/12 qtrs (42%)

Q2 2026Latest

Apr 30, 2026

EPS

$1.09

Est $1.07

+1.9%

Revenue

$2.2B

Est $2.2B

+0.2%

Q1 2026

Jan 29, 2026

EPS

$0.75

Est $0.76

-1.3%

Revenue

$2.0B

Est $2.0B

-2.3%

Q4 2025

Nov 3, 2025

EPS

$1.14

Est $1.16

-1.7%

Revenue

$2.2B

Est $2.3B

-2.5%

Q3 2025

Jul 31, 2025

EPS

$1.60

Est $1.72

-7.0%

Revenue

$2.3B

Est $2.4B

-2.8%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 30, 2026	$1.09vs $1.07+1.9%	$2.2Bvs $2.2B+0.2%
Q1 2026	Jan 29, 2026	$0.75vs $0.76-1.3%	$2.0Bvs $2.0B-2.3%
Q4 2025	Nov 3, 2025	$1.14vs $1.16-1.7%	$2.2Bvs $2.3B-2.5%
Q3 2025	Jul 31, 2025	$1.60vs $1.72-7.0%	$2.3Bvs $2.4B-2.8%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
LYBLyondellBasell Industries N.V.Direct Competitor	23.67B	73.48	-31.27	-25.18%	-3.44%	-7.2%	1.56
CECelanese CorporationDirect Competitor	6.95B	62.12	-5.84	-7.16%	-10.79%	-21.51%	2.89
HUNHuntsman CorporationDirect Competitor	2.63B	15.10	-9.50	-5.85%	-5.69%	-8.14%	0.92
AVNTAvient CorporationDirect Competitor	3.47B	37.84	42.52	0.61%	2.51%	3.46%	0.81
ASHAshland Inc.Direct Competitor	2.5B	54.59	-2.97	-13.68%	-39.03%	-37.54%	0.83
FMCFMC CorporationDirect Competitor	1.85B	14.79	-0.83	-18.34%	-72.93%	-82.27%	2.00
DOWDow Inc.Product Competitor	27.71B	38.50	-10.43	-6.97%	-7.02%	-15.35%	1.12
DDDuPont de Nemours, Inc.Product Competitor	20.52B	50.06	-26.91	-44.7%	-0.3%	-0.15%	0.23

Compare EMN vs Peers

Eastman Chemical Company (EMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LYB

Most directly comparable listed peer for EMN.

Scale Benchmark

vs LIN

Larger-name benchmark to compare EMN against a more recognizable public peer.

Peer Set

Compare Top 5

vs LYB, CE, HUN, AVNT

EMN Income Statement

Eastman Chemical Company (EMN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	9.51B	10.12B	9.25B	8.46B	10.48B	10.54B	9.2B	9.38B	8.75B	8.64B
Revenue Growth %	6.36%	6.39%	-8.64%	-8.47%	23.85%	0.5%	-12.69%	2%	-6.71%	-7.72%
Cost of Goods Sold	7.03B	7.69B	7B	6.46B	7.96B	8.48B	7.14B	7.09B	6.91B	6.93B
COGS % of Revenue	73.9%	76%	75.69%	76.31%	75.98%	80.48%	77.58%	75.59%	78.93%	-
Gross Profit	2.48B▲ 0%	2.43B▼ 2.2%	2.25B▼ 7.5%	2B▼ 10.8%	2.52B▲ 25.6%	2.06B▼ 18.3%	2.06B▲ 0.3%	2.29B▲ 11.1%	1.84B▼ 19.5%	1.71B▲ 0%
Gross Margin %	26.1%	24%	24.31%	23.69%	24.02%	19.52%	22.42%	24.41%	21.07%	19.77%
Gross Profit Growth %	1.14%	-2.17%	-7.45%	-10.81%	25.59%	-18.35%	0.29%	11.06%	-19.48%	-
Operating Expenses	956M	956M	925M	880M	1.05B	972M	966M	914M	913M	900M
OpEx % of Revenue	10.05%	9.44%	10%	10.4%	10.01%	9.23%	10.5%	9.74%	10.43%	-
Selling, General & Admin	729M	721M	691M	654M	795M	708M	727M	664M	658M	652M
SG&A % of Revenue	7.66%	7.12%	7.47%	7.73%	7.58%	6.72%	7.9%	7.08%	7.52%	-
Research & Development	214M	235M	234M	226M	254M	264M	239M	250M	255M	248M
R&D % of Revenue	2.25%	2.32%	2.53%	2.67%	2.42%	2.51%	2.6%	2.66%	2.91%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income	1.53B▲ 0%	1.47B▼ 3.5%	1.32B▼ 10.2%	1.13B▼ 15.0%	1.47B▲ 30.6%	1.08B▼ 26.2%	1.1B▲ 1.1%	1.38B▲ 25.5%	931M▼ 32.3%	808M▲ 0%
Operating Margin %	16.05%	14.55%	14.31%	13.29%	14.01%	10.29%	11.92%	14.67%	10.64%	9.35%
Operating Income Growth %	-0.97%	-3.54%	-10.18%	-14.97%	30.58%	-26.21%	1.11%	25.55%	-32.34%	-
EBITDA	2.11B	2.07B	1.93B	1.7B	2.01B	1.56B	1.59B	1.89B	1.44B	1.2B
EBITDA Margin %	22.19%	20.49%	20.9%	20.07%	19.15%	14.82%	17.33%	20.09%	16.5%	13.83%
EBITDA Growth %	-0.52%	-1.75%	-6.8%	-12.11%	18.13%	-22.22%	2.11%	18.26%	-23.4%	-37.89%
D&A (Non-Cash Add-back)	584M	601M	610M	574M	538M	477M	498M	509M	513M	387M
EBIT	1.53B	1.54B	1.12B	735M	1.27B	1.16B	1.31B	1.29B	776M	479M
Net Interest Income	-241M	-235M	-218M	-201M	-189M	-182M	-215M	-200M	-208M	-159M
Interest Income	3M	3M	3M	4M	3M	6M	10M	16M	0	5M
Interest Expense	244M	238M	221M	205M	192M	188M	225M	216M	208M	216M
Other Income/Expense	-238M	-163M	-421M	-595M	-387M	-107M	-9M	-298M	-363M	-357M
Pretax Income	1.3B▲ 0%	1.31B▲ 0.6%	902M▼ 31.1%	530M▼ 41.2%	1.08B▲ 104.2%	977M▼ 9.7%	1.09B▲ 11.3%	1.08B▼ 0.8%	568M▼ 47.3%	451M▲ 0%
Pretax Margin %	13.69%	12.94%	9.75%	6.26%	10.32%	9.27%	11.82%	11.49%	6.49%	5.22%
Income Tax	-177M	226M	140M	41M	215M	181M	191M	170M	93M	52M
Effective Tax Rate %	-13.59%	17.25%	15.52%	7.74%	19.87%	18.53%	17.57%	15.77%	16.37%	11.53%
Net Income	1.47B▲ 0%	1.08B▼ 26.7%	759M▼ 29.7%	478M▼ 37.0%	857M▲ 79.3%	793M▼ 7.5%	894M▲ 12.7%	905M▲ 1.2%	474M▼ 47.6%	399M▲ 0%
Net Margin %	15.49%	10.67%	8.21%	5.65%	8.18%	7.53%	9.72%	9.65%	5.42%	4.62%
Net Income Growth %	70.21%	-26.73%	-29.72%	-37.02%	79.29%	-7.47%	12.74%	1.23%	-47.62%	-56.72%
Net Income (Continuing)	1.39B	1.08B	762M	489M	867M	796M	896M	908M	475M	399M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	77M	75M	74M	85M	84M	83M	72M	73M	76M	77M
EPS (Diluted)	10.09▲ 0%	7.56▼ 25.1%	5.48▼ 27.5%	3.50▼ 36.1%	6.25▲ 78.6%	6.35▲ 1.6%	7.49▲ 18.0%	7.67▲ 2.4%	4.10▼ 46.5%	-▲ 0%
EPS Growth %	72.77%	-25.07%	-27.51%	-36.13%	78.57%	1.6%	17.95%	2.4%	-46.54%	-55.98%
EPS (Basic)	10.18	7.65	5.52	3.53	6.35	6.42	7.54	7.75	4.13	-
Diluted Shares Outstanding	146.1M	142.9M	138.5M	136.5M	137.1M	124.9M	119.4M	117.9M	115.6M	0
Basic Shares Outstanding	144.8M	141.2M	137.4M	135.5M	134.9M	123.5M	118.6M	116.7M	114.7M	0
Dividend Payout Ratio	20.08%	29.44%	45.19%	74.9%	43.76%	48.05%	42.06%	41.88%	80.38%	-

EMN Balance Sheet

Eastman Chemical Company (EMN) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	3.14B	3.37B	3.32B	3.54B	4.65B	3.78B	3.48B	4.1B	3.65B	4.06B
Cash & Short-Term Investments	191M	226M	204M	564M	459M	493M	548M	837M	566M	665M
Cash Only	191M	226M	204M	564M	459M	493M	548M	837M	566M	665M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	1.39B	1.48B	1.38B	1.51B	1.58B	1.28B	1.15B	1.17B	999M	949M
Days Sales Outstanding	53.17	53.48	54.27	65.33	55.01	44.24	45.79	45.6	41.66	48.19
Inventory	1.51B	1.58B	1.66B	1.38B	1.5B	1.89B	1.68B	1.99B	1.98B	2.08B
Days Inventory Outstanding	78.34	75.11	86.67	77.93	68.92	81.53	86.08	102.32	104.62	107.25
Other Current Assets	57M	73M	80M	83M	1.1B	114M	96M	104M	100M	364M
Total Non-Current Assets	12.86B	12.63B	12.69B	12.54B	10.87B	10.89B	11.15B	11.11B	11.21B	11.17B
Property, Plant & Equipment	5.61B	5.6B	5.57B	5.55B	5B	5.16B	5.55B	5.62B	5.92B	0
Fixed Asset Turnover	1.70x	1.81x	1.66x	1.53x	2.10x	2.04x	1.66x	1.67x	1.48x	1.98x
Goodwill	4.53B	4.47B	4.43B	4.46B	3.64B	3.66B	3.65B	3.63B	3.67B	3.66B
Intangible Assets	2.37B	2.19B	2.01B	1.79B	1.36B	1.21B	1.14B	1.03B	970M	946M
Long-Term Investments	-893M	-884M	0	0	145M	183M	124M	186M	111M	111M
Other Non-Current Assets	349M	378M	674M	736M	729M	672M	696M	647M	546M	8.64B
Total Assets	16B▲ 0%	15.99B▼ 0.0%	16.01B▲ 0.1%	16.08B▲ 0.5%	15.52B▼ 3.5%	14.67B▼ 5.5%	14.63B▼ 0.2%	15.21B▲ 4.0%	14.86B▼ 2.3%	15.22B▲ 0%
Asset Turnover	0.59x	0.63x	0.58x	0.53x	0.68x	0.72x	0.63x	0.62x	0.59x	0.57x
Asset Growth %	3.51%	-0.03%	0.08%	0.47%	-3.51%	-5.49%	-0.23%	3.96%	-2.33%	0.65%
Total Current Liabilities	1.98B	1.85B	1.79B	2.04B	2.97B	3.25B	2.58B	2.71B	2.65B	2.77B
Accounts Payable	842M	914M	890M	799M	1.23B	1.32B	1.17B	1.31B	1.21B	0
Days Payables Outstanding	43.71	43.37	46.41	45.15	56.27	56.78	59.84	67.37	63.99	66.53
Short-Term Debt	393M	243M	171M	349M	797M	1.13B	593M	499M	642M	0
Deferred Revenue (Current)	399M	94M	0	0	0	0	0	0	0	0
Other Current Liabilities	548M	417M	373M	390M	326M	391M	218M	379M	396M	2.77B
Current Ratio	1.59x	1.82x	1.86x	1.74x	1.56x	1.16x	1.35x	1.51x	1.37x	1.37x
Quick Ratio	0.82x	0.96x	0.93x	1.06x	1.06x	0.58x	0.70x	0.78x	0.63x	0.63x
Cash Conversion Cycle	87.8	85.22	94.53	98.11	67.66	69	72.03	80.54	82.29	88.91
Total Non-Current Liabilities	8.54B	8.27B	8.19B	7.94B	6.76B	6.18B	6.53B	6.65B	6.17B	6.37B
Long-Term Debt	6.15B	5.92B	5.61B	5.27B	4.57B	4.03B	4.42B	4.66B	4.32B	0
Capital Lease Obligations	5M	0	0	0	157M	0	120M	96M	117M	117M
Deferred Tax Liabilities	893M	884M	915M	848M	810M	671M	601M	533M	669M	2.3B
Other Non-Current Liabilities	1.49B	1.46B	1.66B	1.82B	1.22B	1.48B	1.38B	1.36B	1.07B	10.14B
Total Liabilities	10.52B	10.12B	9.98B	9.97B	9.73B	9.43B	9.1B	9.36B	8.82B	9.14B
Total Debt	6.54B	6.17B	5.78B	5.62B	5.52B	5.15B	5.14B	5.26B	5.08B	0
Net Debt	6.35B	5.94B	5.58B	5.05B	5.06B	4.66B	4.59B	4.42B	4.51B	-665M
Debt / Equity	1.17x	1.05x	0.96x	0.92x	0.95x	0.98x	0.93x	0.90x	0.84x	0.84x
Debt / EBITDA	3.10x	2.97x	2.99x	3.31x	2.75x	3.30x	3.22x	2.79x	3.52x	0.00x
Net Debt / EBITDA	3.01x	2.86x	2.89x	2.97x	2.52x	2.98x	2.88x	2.35x	3.12x	3.12x
Interest Coverage	6.26x	6.48x	5.05x	3.59x	6.64x	6.16x	5.82x	5.99x	3.73x	2.22x
Total Equity	5.57B▲ 0%	5.88B▲ 5.5%	6.03B▲ 2.6%	6.11B▲ 1.3%	5.79B▼ 5.2%	5.24B▼ 9.5%	5.53B▲ 5.6%	5.85B▲ 5.8%	6.04B▲ 3.2%	6.09B▲ 0%
Equity Growth %	20.56%	5.51%	2.62%	1.26%	-5.24%	-9.54%	5.62%	5.82%	3.16%	11.19%
Book Value per Share	38.13	41.13	43.55	44.75	42.22	41.92	46.31	49.64	52.22	52.22
Total Shareholders' Equity	5.49B	5.8B	5.96B	6.02B	5.7B	5.15B	5.46B	5.78B	5.96B	6.01B
Common Stock	2M	2M	2M	2M	2M	2M	2M	2M	2M	2M
Retained Earnings	6.8B	7.57B	7.96B	8.08B	8.56B	8.97B	9.49B	10.01B	10.11B	10.11B
Treasury Stock	-3.17B	-3.58B	-3.9B	-3.96B	-4.86B	-5.93B	-6.08B	-6.38B	-6.49B	0
Accumulated OCI	-209M	-245M	-214M	-273M	-182M	-205M	-319M	-314M	-160M	-141M
Minority Interest	77M	75M	74M	85M	84M	83M	72M	73M	76M	77M

EMN Cash Flow Statement

Eastman Chemical Company (EMN) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	1.66B	1.54B	1.5B	1.46B	1.62B	975M	1.37B	1.29B	970M	970M
Operating CF Margin %	17.42%	15.24%	16.26%	17.19%	15.44%	9.25%	14.94%	13.72%	11.08%	-
Operating CF Growth %	19.64%	-6.88%	-2.53%	-3.26%	11.27%	-39.78%	40.92%	-6.33%	-24.63%	-24.07%
Net Income	1.39B	1.08B	762M	489M	867M	796M	896M	908M	474M	399M
Depreciation & Amortization	587M	604M	611M	574M	538M	477M	498M	509M	513M	518M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	-49M
Deferred Taxes	-394M	-51M	23M	-111M	-38M	-136M	-102M	-52M	141M	139M
Other Non-Cash Items	-67M	-21M	134M	338M	279M	-175M	-209M	-49M	28M	-294M
Working Capital Changes	143M	-73M	-26M	165M	-27M	13M	291M	-29M	-186M	287M
Change in Receivables	-53M	16M	170M	-31M	-281M	93M	126M	28M	61M	-69M
Change in Inventory	-71M	-224M	-80M	291M	-389M	-430M	201M	-344M	24M	25M
Change in Payables	123M	90M	-27M	-100M	554M	60M	-190M	188M	-76M	-4M
Cash from Investing	-643M	-463M	-480M	-394M	-29M	392M	-432M	-534M	-462M	-435M
Capital Expenditures	-649M	-528M	-425M	-383M	-555M	-611M	-828M	-599M	-546M	-502M
CapEx % of Revenue	6.82%	5.22%	4.6%	4.52%	5.29%	5.8%	9%	6.38%	6.24%	-
Acquisitions	-4M	-3M	-48M	-1M	553M	997M	379M	38M	38M	38M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	10M	68M	-7M	-10M	-27M	6M	17M	27M	46M	29M
Cash from Financing	-1.01B	-1.04B	-1.04B	-704M	-1.69B	-1.32B	-888M	-454M	-797M	-332M
Debt Issued (Net)	-369M	-316M	-370M	-307M	-350M	76M	-338M	198M	-304M	-285M
Equity Issued (Net)	-350M	-400M	-325M	-60M	-1B	-1B	-150M	-300M	-100M	-100M
Dividends Paid	-296M	-318M	-343M	-358M	-375M	-381M	-376M	-379M	-381M	-381M
Share Repurchases	-350M	-400M	-325M	-60M	-1B	-1B	-150M	-300M	-100M	-100M
Other Financing	9M	-6M	-5M	21M	35M	-14M	-24M	27M	-12M	434M
Net Change in Cash	10M▲ 0%	35M▲ 250.0%	-22M▼ 162.9%	360M▲ 1736.4%	-105M▼ 129.2%	34M▲ 132.4%	55M▲ 61.8%	289M▲ 425.5%	-837M▼ 389.6%	-319M▲ 0%
Free Cash Flow	1.01B▲ 0%	1.01B▲ 0.7%	1.07B▲ 5.7%	1.06B▼ 1.3%	1.04B▼ 1.7%	364M▼ 65.0%	546M▲ 50.0%	688M▲ 26.0%	424M▼ 38.4%	498M▲ 0%
FCF Margin %	10.59%	10.03%	11.6%	12.51%	9.93%	3.46%	5.94%	7.33%	4.84%	5.76%
FCF Growth %	32.81%	0.69%	5.71%	-1.3%	-1.7%	-65.03%	50%	26.01%	-38.37%	-13.39%
FCF per Share	6.90	7.10	7.75	7.76	7.59	2.91	4.57	5.84	3.67	3.67
FCF Conversion (FCF/Net Income)	1.12x	1.43x	1.98x	3.04x	1.89x	1.23x	1.54x	1.42x	2.05x	1.25x
Interest Paid	0	0	0	0	0	0	214M	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

EMN Key Ratios

Eastman Chemical Company (EMN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	28.92%	18.87%	12.75%	7.87%	14.41%	14.39%	16.61%	15.9%	7.97%	6.69%
Return on Invested Capital (ROIC)	9.98%	9.31%	8.47%	7.41%	10.01%	7.84%	8.21%	10.12%	6.71%	6.71%
Gross Margin	26.1%	24%	24.31%	23.69%	24.02%	19.52%	22.42%	24.41%	21.07%	19.77%
Net Margin	15.49%	10.67%	8.21%	5.65%	8.18%	7.53%	9.72%	9.65%	5.42%	4.62%
Debt / Equity	1.17x	1.05x	0.96x	0.92x	0.95x	0.98x	0.93x	0.90x	0.84x	0.84x
Interest Coverage	6.26x	6.48x	5.05x	3.59x	6.64x	6.16x	5.82x	5.99x	3.73x	2.22x
FCF Conversion	1.12x	1.43x	1.98x	3.04x	1.89x	1.23x	1.54x	1.42x	2.05x	1.25x
Revenue Growth	6.36%	6.39%	-8.64%	-8.47%	23.85%	0.5%	-12.69%	2%	-6.71%	-7.72%

EMN SEC Filings & Documents

Eastman Chemical Company (EMN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Feb 20, 2026·SEC

Material company update

Jan 29, 2026·SEC

10-K Annual Reports

FY 2026

Feb 13, 2026·SEC

FY 2025

Feb 14, 2025·SEC

10-Q Quarterly Reports

FY 2026

May 1, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 1, 2025·SEC

EMN Frequently Asked Questions

Eastman Chemical Company (EMN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Eastman Chemical Company (EMN) reported $8.64B in revenue for fiscal year 2025. This represents a 81% increase from $4.78B in 1996.

Eastman Chemical Company (EMN) saw revenue decline by 6.7% over the past year.

Yes, Eastman Chemical Company (EMN) is profitable, generating $399.0M in net income for fiscal year 2025 (5.4% net margin).

Dividend & Returns

Yes, Eastman Chemical Company (EMN) pays a dividend with a yield of 4.35%. This makes it attractive for income-focused investors.

Eastman Chemical Company (EMN) has a return on equity (ROE) of 8.0%. This is below average, suggesting room for improvement.

Eastman Chemical Company (EMN) generated $498.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More EMN

Eastman Chemical Company (EMN) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Eastman Chemical Company(EMN)Earnings, Financials & Key Ratios

EMN Key Insights

✓Strengths

✗Weaknesses

EMN Price & Volume

EMN Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

EMN Recent Earnings

EMN Peer Comparison

Compare EMN vs Peers

vs LYB

vs LIN

Compare Top 5

EMN Income Statement

EMN Balance Sheet

EMN Cash Flow Statement

EMN Key Ratios

EMN SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

EMN Frequently Asked Questions

Explore More EMN

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation